Classical pathological cardiac hypertrophy biomarkers, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), were upregulated in the MI group and reduced in the NOB intervention group (Figure 2(d)). The gene discussed is NPPB; the disease is cardiac hypertrophy.